Bristol-Myers Squibb Company logo
Bristol-Myers Squibb Company BMY
$ 62.15 -0.35%

Annual report 2025
added 02-11-2026

report update icon

Bristol-Myers Squibb Company Long Term Debt Current 2011-2026 | BMY

Annual Long Term Debt Current Bristol-Myers Squibb Company

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
202 M 181 M 162 M 136 M 169 M 2 B 133 M 1.25 B - 749 M - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
2 B 133 M 553 M

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer Long Term Debt Current Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Acer Therapeutics Acer Therapeutics
ACER
104 K - 2.71 % $ 14 M usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
AgeX Therapeutics AgeX Therapeutics
AGE
428 K - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
5.82 M $ 3.66 1.25 % $ 1.09 B canadaCanada
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
Black Diamond Therapeutics Black Diamond Therapeutics
BDTX
3.4 M $ 2.4 -3.04 % $ 132 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
213 K - 1052.0 % $ 415 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
Acasti Pharma Acasti Pharma
ACST
75 K - 4.01 % $ 150 M canadaCanada
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
410 K - 1.93 % $ 17.4 M usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
3.08 M - -0.23 % $ 916 M usaUSA
Alector Alector
ALEC
9.06 M $ 2.12 -12.96 % $ 218 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
317 K - 3.16 % $ 1.9 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
48 K - 10.36 % $ 9.8 M usaUSA
AlloVir AlloVir
ALVR
10.8 M - 4.14 % $ 49.1 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
756 K - - $ 2.17 B usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
271 K - 5.93 % $ 314 M canadaCanada
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
274 K - -11.43 % $ 502 K usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Aravive Aravive
ARAV
2.2 M - -13.39 % $ 1.45 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
428 K - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
Athira Pharma Athira Pharma
ATHA
414 K - - $ 269 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
538 K - 17.91 % $ 11.1 M usaUSA
Altimmune Altimmune
ALT
279 K $ 4.22 -2.09 % $ 300 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Athersys Athersys
ATHX
1.01 M - 3.77 % $ 22.4 M usaUSA
Axcella Health Axcella Health
AXLA
1.59 M - -16.42 % $ 249 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
382 M - - $ 96.9 B britainBritain
AVEO Pharmaceuticals AVEO Pharmaceuticals
AVEO
11 K - - $ 521 M usaUSA
Atreca Atreca
BCEL
3.54 M - -11.76 % $ 5.79 M usaUSA
Apellis Pharmaceuticals Apellis Pharmaceuticals
APLS
7.09 M $ 20.76 -0.95 % $ 2.62 B usaUSA
AVROBIO AVROBIO
AVRO
878 K - 1083.1 % $ 745 M usaUSA
Agenus Agenus
AGEN
2.59 M $ 3.35 0.45 % $ 1.2 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
Agios Pharmaceuticals Agios Pharmaceuticals
AGIO
18.4 M $ 28.99 -4.1 % $ 1.68 B usaUSA
bluebird bio bluebird bio
BLUE
21.2 M - - $ 546 M usaUSA
Brickell Biotech Brickell Biotech
BBI
49 K - -5.38 % $ 6.06 M usaUSA